What's in Quince Therapeutics S.p.A.'s pipeline?

Quince Therapeutics S.p.A. has 4 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Quince Therapeutics S.p.A.'s portfolio?

Top competitors by shared drug class: AIDS Malignancy Consortium, ANI Pharmaceuticals, AbbVie, Acrotech Biopharma Inc., Allergan.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/quince-therapeutics-s-p-a.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Quince Therapeutics S.p.A. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quince Therapeutics S.p.A. pipeline: 0 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
EryDex High dose DSP	EryDex High dose DSP	phase 3	Corticosteroid	Glucocorticoid receptor	Immunology / Inflammatory disease
EryDex Low dose DSP	EryDex Low dose DSP	phase 3	Corticosteroid	Glucocorticoid receptor	Immunology

Therapeutic area mix

Immunology · 1
Immunology / Inflammatory disease · 1
Rheumatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AIDS Malignancy Consortium · 1 shared drug class
ANI Pharmaceuticals · 1 shared drug class
AbbVie · 1 shared drug class
Acrotech Biopharma Inc. · 1 shared drug class
Allergan · 1 shared drug class
Aramis Biosciences, Inc. · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Quince Therapeutics S.p.A.:

Cite this brief

Drug Landscape (2026). Quince Therapeutics S.p.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/quince-therapeutics-s-p-a. Accessed 2026-05-17.